Status:

COMPLETED

Prothrombin Times Outside the Therapeutic Range in Otherwise Stable Patients

Lead Sponsor:

Hamilton Health Sciences Corporation

Conditions:

Atrial Fibrillation

Venous Thromboembolism

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

Warfarin is very effective for the prevention of blood clots (thrombosis). A test of coagulation, the prothrombin time (PT) is used to monitor the effect. The PT response to warfarin can fluctuate as ...

Detailed Description

Setting: Thrombosis Service at HHS - General Hospital. This center monitors the warfarin treatment for 1300 patients in the region. These patient regularly go to a laboratory where they live. Test re...

Eligibility Criteria

Inclusion

  • Patients on long-term warfarin (for prophylaxis of arterial embolism in patients with atrial fibrillation or mechanical heart valve replacement, or secondary prophylaxis after VTE) with a target INR of 2.0-3.0 or 2.5-3.5,
  • Anticoagulant therapy managed by the clinic (HHS - General Hospital) for at least 3 months prior to enrolment, and
  • Maintenance dose of warfarin unchanged for the previous 3 months or longer.
  • The INR result is outside the therapeutic range as follows:
  • For those with target 2.0-3.0: Either an INR of 1.5-1.9 or an INR of 3.1-4.4. For those with target 2.5-3.5: Either an INR of 1.5-2.4 or an INR of 3.6-4.4.

Exclusion

  • Age \<18 years,
  • Long-term (\>1 week) change in any other medication
  • Long-term (\>1 week) change in diet, especially regarding green vegetables.
  • Attending physician believes the patient is not suitable for the study (e.g. psychiatric disorder, history of non-compliance),
  • Failure to obtain telephone consent.

Key Trial Info

Start Date :

July 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2009

Estimated Enrollment :

160 Patients enrolled

Trial Details

Trial ID

NCT00814177

Start Date

July 1 2006

End Date

April 1 2009

Last Update

August 1 2012

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Thrombosis Service, HHS-General Hospital

Hamilton, Ontario, Canada, L8L 2X2

Prothrombin Times Outside the Therapeutic Range in Otherwise Stable Patients | DecenTrialz